Matthew Sorrentino to Humans
This is a "connection" page, showing publications Matthew Sorrentino has written about Humans.
Connection Strength
0.259
-
The Bucksbaum Institute for Clinical Excellence and the Doctor-Patient Relationship: Origins, Programs, and Future Directions. Acad Med. 2023 06 01; 98(6S):S3-S5.
Score: 0.026
-
The Evolution from Hypertension to Heart Failure. Heart Fail Clin. 2019 Oct; 15(4):447-453.
Score: 0.020
-
Redefining Hypertension - Assessing the New Blood-Pressure Guidelines. N Engl J Med. 2018 02 08; 378(6):497-499.
Score: 0.018
-
Pharmacogenomics and cardiology: improving treatment with existing drugs. Pharmacogenomics. 2015; 16(11):1223-6.
Score: 0.014
-
Bleeding risk prediction models in atrial fibrillation. Curr Cardiol Rep. 2014 Jan; 16(1):432.
Score: 0.013
-
Lipid effects of antihypertensive medications. Curr Atheroscler Rep. 2012 Feb; 14(1):70-7.
Score: 0.012
-
Early intervention strategies to lower cardiovascular risk in early nephropathy: focus on dyslipidemia. Cardiol Clin. 2010 Aug; 28(3):529-39.
Score: 0.011
-
Implications of the metabolic syndrome: the new epidemic. Am J Cardiol. 2005 Aug 22; 96(4A):3E-7E.
Score: 0.008
-
Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial. Lancet Neurol. 2025 Apr; 24(4):295-304.
Score: 0.007
-
When to convert atrial fibrillation? Postgrad Med. 2003 Jun; 113(6):28.
Score: 0.006
-
Beta-blockers for congestive heart failure. Compr Ther. 2003; 29(4):210-4.
Score: 0.006
-
Beta blockers for CHF. Adrenergic blockade dramatically reduces morbidity and mortality. Postgrad Med. 2001 Mar; 109(3):49-56.
Score: 0.006
-
Cholesterol reduction to prevent CAD. What do the data show? Postgrad Med. 2000 Dec; 108(7):40-2, 45-6, 49-52.
Score: 0.005
-
Does hypertriglyceridemia increase risk for CAD? Growing evidence suggests it plays a role. Postgrad Med. 2000 Dec; 108(7):77-84.
Score: 0.005
-
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Neurosurgery. 2019 12 01; 85(6):843-853.
Score: 0.005
-
Follow-up to initial episode of atrial fibrillation. Postgrad Med. 1999 Oct 01; 106(4):35.
Score: 0.005
-
Turning up the heat on hypertension. It's time to be more aggressive in finding and treating this silent killer. Postgrad Med. 1999 May 01; 105(5):82-4, 89-93.
Score: 0.005
-
Patient-provider communications about pharmacogenomic results increase patient recall of medication changes. Pharmacogenomics J. 2019 12; 19(6):528-537.
Score: 0.005
-
Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study. Pharmacogenet Genomics. 2019 02; 29(2):31-38.
Score: 0.005
-
Switching from drip to oral diltiazem therapy. Postgrad Med. 1998 Oct; 104(4):37.
Score: 0.005
-
The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients. J Cardiovasc Pharmacol Ther. 2019 01; 24(1):54-61.
Score: 0.005
-
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther. 2017 Nov; 102(5):859-869.
Score: 0.004
-
Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program. Clin Pharmacol Ther. 2017 07; 102(1):106-114.
Score: 0.004
-
Causes of congestive heart failure. Prompt diagnosis may affect prognosis. Postgrad Med. 1997 Jan; 101(1):44-9, 54-6.
Score: 0.004
-
Drug therapy for congestive heart failure. Appropriate choices can prolong life. Postgrad Med. 1997 Jan; 101(1):83-6, 89-90, 93-4.
Score: 0.004
-
Left ventricular outflow tract obstruction as a cause for hypotension and symptoms during dobutamine stress echocardiography. Clin Cardiol. 1996 Mar; 19(3):225-30.
Score: 0.004
-
Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs. Mayo Clin Proc. 2015 Jun; 90(6):716-29.
Score: 0.004
-
Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project". Am J Med Genet C Semin Med Genet. 2014 Mar; 166C(1):68-75.
Score: 0.003
-
Racial disparities in coronary artery disease prevalence. Ann Intern Med. 1993 Oct 15; 119(8):861.
Score: 0.003
-
Mitral valve prolapse. Avoiding complications of a progressive disease. Postgrad Med. 1993 May 01; 93(6):63-6, 69-70, 79.
Score: 0.003
-
Positional right-to-left shunting. Ann Intern Med. 1993 Mar 15; 118(6):473-4.
Score: 0.003
-
Plasma lipoprotein (a) protein concentration and coronary artery disease in black patients compared with white patients. Am J Med. 1992 Dec; 93(6):658-62.
Score: 0.003
-
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, Society of Thoracic Surgeons. J Thorac Cardiovasc Surg. 2012 Jul; 144(1):39-71.
Score: 0.003
-
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: American College of Cardiology Foundation Appropriate Use Criteria Task Force Society for Cardiovascular Angiography and Interventions American Association for Thoracic Surgery American Heart Association, American Society of Echocardiography American Society of Nuclear Cardiology Heart Failure Society of America Heart Rhythm Society, Society of Critical Care Medicine Society of Cardiovascular Computed Tomography Society for Cardiovascular Magnetic Resonance Society of Thoracic Surgeons. Catheter Cardiovasc Interv. 2012 Sep 01; 80(3):E50-81.
Score: 0.003
-
Techniques for IABP timing, use--and discontinuance. Counterpulsation can reduce ischemia and improve hemodynamics. J Crit Illn. 1992 Apr; 7(4):597-604.
Score: 0.003
-
Arterial thrombosis in a previously healthy woman. Postgrad Med. 1992 Mar; 91(4):247-8, 251.
Score: 0.003
-
Patent foramen ovale associated with platypnea and orthodeoxia. Chest. 1991 Oct; 100(4):1157-8.
Score: 0.003
-
Predictors of hypertension control in a diverse general cardiology practice. J Clin Hypertens (Greenwich). 2010 Aug; 12(8):570-7.
Score: 0.003
-
Echocardiographic determination of myocardial mass: a review. Am J Physiol Imaging. 1988; 3(2):109-13.
Score: 0.002
-
The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Int J Cardiol. 2005 Oct 10; 104(3):264-8.
Score: 0.002
-
Diets and cardiovascular disease: an evidence-based assessment. J Am Coll Cardiol. 2005 May 03; 45(9):1379-87.
Score: 0.002
-
Physician-performed point-of-care echocardiography using a laptop platform compared with physical examination in the cardiovascular patient. J Am Coll Cardiol. 2001 Jun 15; 37(8):2013-8.
Score: 0.001
-
The effects of intraperitoneal local anesthetic on analgesic requirements and endocrine response after laparoscopic cholecystectomy: a randomized double-blind controlled study. J Laparoendosc Surg. 1994 Dec; 4(6):405-12.
Score: 0.001
-
Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. Anesth Analg. 1994 Dec; 79(6):1133-40.
Score: 0.001